Roche hit by failure of trial for cancer drug Kadcyla By: MarketWatch December 19, 2014 at 10:16 AM EST Roche Holding says a late-stage study of the breast-cancer drug Kadcyla failed to yield superior results to an existing treatment. Read More >> Related Stocks: Immunogen Inc